All hands on deck: new short therapy for stubborn anxiety in teens

NCT ID NCT06152913

Symptom relief Sponsor: Accare Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new, short, and intensive therapy called HANDS-ON for 12 teens (ages 10-18) with anxiety or obsessive-compulsive disorder (OCD) who hadn't improved with standard therapy. The treatment involved personalized exposure exercises done at home and school, with help from parents and teachers. Researchers measured progress daily and interviewed families to see if this approach could help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance: HANDS-ON treatment (a personalized, brief, intensive exposure-based behavioral intervention)
What this could lead to: If it works, this could offer a new option for young people with anxiety or OCD who haven't gotten better with standard therapy.
What could go wrong: This was a very small study (12 participants) with no control group, so results may not apply to everyone. It's too early to know if it works better than other treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Dec 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 10-18 years old; * Meeting DSM-5 criteria for an anxiety disorder/OCD, based on a semi-structured interview (SCID-5 Jr; \[12\]) and clinical judgement of an experienced and authorized clinician; * Non-responder to previous CBT (insufficient benefits from previous CBT for AD/OCD). Comorbid diagnoses are allowed except for those interfering with safety or warranting immediate treatment, e.g., acute suicidality or psychosis. Exclusion Criteria: * Severe psychiatric symptoms other than anxiety/OCD interfering with safety or warranting immediate intervention, e.g. psychosis or acute suicidality.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder obsessive-compulsive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety disorders Obsessive - compulsive disorder Obsessive-compulsive disorder in adolescence Obsessive-compulsive disorder in children

All hands on deck: new short therapy for stubborn anxiety in teens

What the study statuses mean